Outlook Therapeutics, Inc. (OTLK) NASDAQ

1.00

+0.0736(+7.94%)

Updated at September 10 04:00PM

Currency In USD

Valuation

Market Cap99.05M
Enterprise Value113.86M
P/E Ratio-0.85
PEG Ratio0
Price/Sales Ratio26.51
Price/Book Ratio-0.99
Enterprise/Revenue41.91
Enterprise/EBITDA-1.45

Fiscal Year

Fiscal YearSeptember 30, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-25.93
Operating Margin-43.35

Management Effectiveness

Return On Assets-1.94
Return On Equity0.9

Income Statement

Revenue0
Revenue/Share0.05
Gross Profit-113,859
EBITDA-72.09M
Net Income-75.37M
Diluted EPS-4.06

Balance Sheet

Total Cash8.9M
Total Cash/Share0.24
Total Debt34.7M
Total Debt/Equity-0.93
Current Ratio0.67
Book Value Per Share-1.01

Price History

52-Week Change-85.78
52-Week High7.26
52-Week Low0.79
Moving Average 50 Days1.93
Moving Average 200 Days1.82

Statistics

Average Volume3.16M
Shares Outstanding44.42M
% Held by Institutions17.24

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateMarch 14, 2024